Risankizumab (anti-IL-23)
Product Specifications
CAS Number
1612838-76-2
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882497-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/2497R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
